Director Lee Rauch resigns from Ensysce board over severance package dispute

Ensysce Biosciences, Inc.

Lee Rauch resigned effective March 24, 2026, citing disagreement with board-approved severance packages.
Packages provide up to $205,475 in potential severance for CFO and three managers during strategic review.
CFO retention package increased from 6 to 9 months; packages contingent on non-retention in any strategic deal.
Board approved packages on March 27, 2026; Rauch had previously expressed other disagreements.
Company continues evaluating strategic alternatives for its business.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.